Use of estrogen for prevention and treatment of osteoporosis

Endocrine

Volumn 6, Issue 2, 1997, Pages 207-211

  Marcus, Robert ^a,b  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN; PIPERAZINE ESTRONE SULFATE; TAMOXIFEN;

CONFERENCE PAPER; ESTROGEN THERAPY; FEMALE; HUMAN; MENOPAUSE; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; PRIORITY JOURNAL; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0031010225     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/bf02738967     Document Type: Conference Paper

References (29)

1. Blunt, B. A., Klauber, M. R., Barrett-Connor, E. L., and Edelstein, S. L. (1994). J. Bone Min. Res. 9, 1333-1338.
2. Greenspan, S., Maitland, L. A., Myers, E. R., Krasnow, M. B., and Tamiko, H. K. (1994). J. Bone Min. Res. 9, 1959-1965.
3. Harris, S., Dallal, G. E., and Dawson-Hughes, B. (1992). Calcif. Tissue Int. 50, 19-23.
4. Lindsay, R., Hart, D. M., Aitken, J. M., MacDonald, E. B., Anderson, J. B., and Clarke, A. C. (1976). Lancet i, 1038-1040.
5. Lindsay, R., Hart, D. M., Forrest, C., and Baird, C. (1980). Lancet ii, 1151-1153.
6. Genant, H. K., Christopher, C. E., Ettinger, B., and Gordan, G. S. (1982). Ann. Int. Med. 97, 699-705.
7. Recker, R. R., Saville, P. D., and Heaney, R. P. (1977). Ann. Int. Med. 87, 649-655.
8. Horsman, A., Gallagher, J. C., Simpson, M., and Nordin, B. E. C. (1977). Br. Med. J. 2, 789-792.
9. Christansen, C., Christensen, M. S., McNair, P., Hagen, C., Stocklund, K., and Transbøl, I. (1980). Eur. J. Clin. Invest. 10, 273-279.
10. Lindsay, R. and Tohme, J. F. (1990). Obstet. Gynecol. 76, 290-295.
11. Quigley, M. E. T., Martin, P. L., Burnier, A. M., and Brooks, P. (1987). Am. J. Obstet. Gynecol. 156, 1516-1523.
12. The PEPI Investigators. (1995). The Postmenopausal Estrogen/Progestins Interventions Trial: rationale, design, and conduct. Controlled Clinical Trials 16, Supplement 1S-65S.
13. PEPI Trial Investigators Writing Group. (1996). Hormonal effects on bone mineral density in the spine and hip: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 276, 1389-1396.
14. Ettinger, B., Genant, H. K., Steiger, P., and Madvig, P. (1992). Am. J. Obstet. Gynecol. 166, 479-488.
15. Ettinger, B., Genant, H. K., and Cann, C. E. (1987). Ann. Int. Med. 106, 40-45.
16. Gallagher, J. C. and Baylink, D. (1990). J. Bone Miner Res. Suppl. 2, 802, Abstract.
17. Stevenson, J. C., Cust, M. P., Gangar, K. F., Hillard, T. C., Lees, B., and Whitehead, M. I. (1990). Lancet ii, 265-269.
18. Nachtigall, L. E., Nachtigall, R. H., Nachtigall, R. D., and Beckmann, E. M. (1979). Obstet. Gynecol 53, 277-281.
19. Hutchinson, T. A., Polansky, S. M., and Feinstein, A. R. (1979). Lancet ii, 705-709.
20. Weiss, N. S., Ure, C. L., Ballard, J. H., Williams, A. R., and Daling, J. R. (1980). N. Engl. J. Med. 303, 1195-1198.
21. Kanis, J. A., Johnell, O., Gullberg, B., Allander, E., Dilsen, G., and Gennari, C. (1992). Br. Med. J. 305, 1124-1128.
22. Felson, D. T., Zhang, Y., Hannon, M. T., Kiel, D. P., Wilson, P. W., and Anderson, J. J. (1993). N. Engl. J. Med. 329, 1141-1146.
23. Cauley, J. A., Seeley, D. G., Enstrud, K., Ettinger, B., Black, D., and Cummings, S. R. (1995). Ann. Int. Med. 122, 9-16.
24. Lindsay, R., Hart, D. M., MacLean, A., Clarke, A. C., Kraszewski, A., and Garwood, J. (1978). Lancet i, 1325-1327.
25. Christiansen, C., Christensen, M. S., and Transbøl, I. (1981). Lancet i, 459-461.
26. Gotfredsen, A., Christiansen, C., and Palshof, T. (1984). Cancer 53, 853-857.
27. Love, R., Mazess, R., Tormey, D., Barden, H., Newcomb, P., and Jordan, V. (1988). Breast Cancer Res. Treat. 12, 297-301.
28. Turken, S., Siris, E., Seldin, D., Plaster, E., Hyman, G., and Lindsay, R. (1989). J. Natl. Cancer Inst. 81, 1086-1088.
29. Black, L. J., Sato, M., and Rowley, E. R. (1994). J. Clin. Invest. 93, 62-69.